Sauter la navigation.

CONTACT

Targeting Mitochondria 2022: Intervenants et sujets confirmés

Date

15/03/2022

Les intervenants listés ci-dessous participeront à la 13e réunion annuelle mondiale de WMS sur le ciblage des mitochondries "Targeting Mitochondria 2022" qui se tiendra à Berlin du 26 au 28 octobre.

 

Targeting Mitochondria 2022- Jan SmeitnikThe Randomized Controlled Phase 2b KHENERGYZETrial of Sonlicromanol in Primary Mitochondrial Disease MELAS Spectrum Disorders: Topline Results

Jan SmeitinkKhondrion B.V., Netherlands
Targeting Mitochondria 2022- Marc Germain

Marc GermainUniversité du Québec à Trois-Rivières, Canada
Mitochondrial, exosomal miR137-COX6A2 in schizophreniaTargeting Mitochondria 2022-  Ines Khadimallah

Ines Khadimallah, Lausanne University Hospital, Switzerland
Targeting Mitochondria 2022- Cora Weigert

Cora WeigertUniversity Hospital Tuebingen, Germany
Targeting Mitochondria 2022 - Pedro- Silva PinheiroThe Potential of Mitochondrial Genome Engineering 

Pedro Silva-Pinheiro University of Cambridge, United Kingdom
Targeting Mitochondria 2022- Dr. Maria FazzariGM1 oligosaccharide as mitochondrial modulator: implications in neurological diseases 

Maria Fazzari,  University of Milano, Italy
Lefkothea C. Papadopoulou,Aristotle University of Thessaloniki, Greece

Jessica Spinelli, Whitehead Institute for Biomedical Research, USA

Marc G. Jeschke, University of Toronto, Canada

Ian J. Holt, Biodonostia Health Research Institute, Spain

Michael Teitell, University of California, USA
Raghavan Pillai Raju, Medical College of Georgia, USA
Camilla Bean, University of Padova, Italy